----

----

|   x                                                       | Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934        |
|----------------------------------------------------------------|------------------------------------------------------------------------------------------|
| For the quarterly period ended  September 30, 2010        |
|                                                           |
| o                                                              |      Transition report under Section 13 or 15(d) of the Exchange Act |
|                                                           |                                                                                     |
| For the transaction period from _____________ to _____________ |
|                                                           |
| Commission file number 333-62216                               |

| HEALTH DISCOVERY CORPORATION(Exact name of registrant as specified in its charter)             |
|------------------------------------------------------------------------------------------------|
|                                                                                           |
| Georgia(State or other jurisdiction of incorporation or organization)                          | 74-3002154(IRS Employer Identification No.) |
|                                                                                           |
| 2 East Bryan Street, Suite #502Savannah, Georgia 31401(Address of principal executive offices) |

|                                                                                              |
|---------------------------------------------------------------------------------------------------|
| 912-443-1987                                                                                      |
| (Registrant's telephone number, including area code)                                              |
|   (Former name, former address and former fiscal year,if changed since the last report) |

| Large Accelerated Filer o |   | Non-Accelerated Filer o                       |
|---------------------------|--------|-----------------------------------------------|
|                      |   |                                          |
|                      |   | (do not check if a smaller reporting company) |
|                      |   |                                     |
| Accelerated Filer o       |   | Smaller Reporting Company x                   |

----

| Class:                     | Outstanding as of November 15, 2010 |
|----------------------------|-------------------------------------|
|                       |                                |
| Common Stock, no par value | 228,850,747                         |
|                       |                                |
| Series A Preferred Stock   | 0                                   |
|                       |                                |
| Series B Preferred Stock   | 19,402,675                          |

----

|                                                                                                                                                                              |   |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|
| PART I  -- FINANCIAL INFORMATION                                                                                                                                        | 2      |
|                                                                                                                                                                              |   |
|     Item 1.  Unaudited Financial Statements                                                                                                         | 2      |
|                                                                                                                                                                              |   |
|        Balance Sheet                                                                                                                           | 2      |
|                                                                                                                                                                              |   |
|        Statements of Operations                                                                                                                | 3      |
|                                                                                                                                                                              |   |
|        Statements of Cash Flows                                                                                                                | 4      |
|                                                                                                                                                                              |   |
|        Notes to Financial Statements                                                                                                           | 5      |
|                                                                                                                                                                              |   |
|             Item 2.  Managements's Discussion and Analysis of Financial Condition and Results of Operations | 11     |
|                                                                                                                                                                              |   |
|     Item 3.  Quantitative and Qualitative Disclosures About Market Risk                                                                             | 16     |
|                                                                                                                                                                              |   |
|             Item 4T.Controls and Procedures.                                                                          | 16     |
|                                                                                                                                                                              |   |
| PART II -- OTHER INFORMATION                                                                                                                                                      | 17     |
|                                                                                                                                                                              |   |
|     Item 1.  Legal Proceedings                                                                                                                      | 17     |
|                                                                                                                                                                              |   |
|     Item 1A. Risk Factors                                                                                                                                     | 17     |
|                                                                                                                                                                              |   |
|     Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds                                                                            | 17     |
|                                                                                                                                                                              |   |
|     Item 3.  Defaults Upon Senior Securities                                                                                                        | 18     |
|                                                                                                                                                                              |   |
|     Item 4.  Removed and Reserved                                                                                                                   | 18     |
|                                                                                                                                                                              |   |
|     Item 5.  Other Information.                                                                                                                     | 18     |
|                                                                                                                                                                              |   |
|     Item 6.  Exhibits.                                                                                                                              | 18     |
|                                                                                                                                                                              |   |
| SIGNATURES                                                                                                                                                                        | 19     |

----

|  Assets                                                                                                                                                                                                                                                                     |   |            |                  |   |         |   |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|-----------------|-----------------------|--------|--------------|--------|
|                                                                                                                                                                                                                                                                             |   | September 30,   |                  |   | December 31, |   |
|                                                                                                                                                                                                                                                                             |   | 2010(unaudited) |                  |   | 2009    |   |
| Current Assets                                                                                                                                                                                                                                                                   |   |            |                  |   |         |   |
|      Cash                                                                                                                                                                                                                                               |   | $               | 4,604,746             |   |         | $      | 2,328,912 |   |
|      Certificates of Deposit                                                                                                                                                                                                                                 |   |            | 150,793               |   |         |   | 622,358 |   |
|      Accounts Receivable                                                                                                                                                                                                                                |   |            | 444,311               |   |         |   | 112,500 |   |
|      Prepaid Expenses and Other Assets                                                                                                                                                                                                                  |   |            | 122,044               |   |         |   | 15,569 |   |
|                                                                                                                                                                                                                                                                             |   |            |                  |   |         |   |   |   |
|           Total Current Assets                                                                                                                                                                                                 |   | $               | 5,321,894             |   |         | $      | 3,079,339 |   |
|                                                                                                                                                                                                                                                                             |   |            |                  |   |         |   |   |   |
| Equipment, Less Accumulated Depreciation of $25,345 and $19,251                                                                                                                                                                                                                  |   |            | 23,737                |   |         |   | 24,667 |   |
|                                                                                                                                                                                                                                                                             |   |            |                  |   |         |   |   |   |
| Other Assets                                                                                                                                                                                                                                                                     |   |            |                  |   |         |   |   |   |
|      Deferred Charges                                                                                                                                                                                                                                   |   |            | 53,484                |   |         |   | 10,336 |   |
|      Patents, Less Accumulated Amortization of $1,665,452 and $1,468,412                                                                                                                                                                                |   |            | 2,320,342             |   |         |   | 2,517,382 |   |
|                                                                                                                                                                                                                                                                             |   |            |                  |   |         |   |   |   |
|           Total Assets                                                                                                                                                                                                         |   | $               | 7,719,457             |   |         | $      | 5,631,724 |   |
|                                                                                                                                                                                                                                                                             |   |            |                  |   |         |   |   |   |
|  Liabilities and Stockholders’ Equity                                                                                                                                                                                                                                 |   |            |                  |   |         |   |   |   |
|                                                                                                                                                                                                                                                                             |   |            |                  |   |         |   |   |   |
| Current Liabilities                                                                                                                                                                                                                                                              |   |            |                  |   |         |   |   |   |
|      Accounts Payable – Trade                                                                                                                                                                                                                     |   | $               | 511,703               |   |         | $      | 570,837 |   |
|      Accrued Liabilities                                                                                                                                                                                                                                |   |            | 173,082               |   |         |   | 214,122 |   |
|      Accrued Settlement Charges (Note G)                                                                                                                                                                                       |   |            | 396,779               |   |         |   | - |   |
|  Dividends Payable                                                                                                                                                                                                                                                          |   |            | 23,518                |   |         |   | - |   |
|      Deferred Revenue                                                                                                                                                                                                                                   |   |            | 114,035               |   |         |   | 39,375 |   |
|                                                                                                                                                                                                                                                                             |   |            |                  |   |         |   |   |   |
|           Total Current Liabilities                                                                                                                                                                                            |   |            | 1,219,117             |   |         |   | 824,334 |   |
|                                                                                                                                                                                                                                                                             |   |            |                  |   |         |   |   |   |
| Long Term Liabilities                                                                                                                                                                                                                                                            |   |            |                  |   |         |   |   |   |
|      Deferred Revenue                                                                                                                                                                                                                                   |   |            | 860,371               |   |         |   | 504,560 |   |
|      Dividends Payable                                                                                                                                                                                                                                  |   |            | 156,120               |   |         |   | 14,993 |   |
|                                                                                                                                                                                                                                                                             |   |            |                  |   |         |   |   |   |
|           Total Liabilities                                                                                                                                                                                                    |   |            |  2,235,608       |   |         |   |  1,343,887 |   |
|                                                                                                                                                                                                                                                                             |   |            |                  |   |         |   |   |   |
| Commitments and Contingencies (Note H)                                                                                                                                                                                                                                           |   |            |                  |   |         |   |   |   |
|                                                                                                                                                                                                                                                                             |   |            |                  |   |         |   |   |   |
| Stockholders’ Equity                                                                                                                                                                                                                                                       |   |            |                  |   |         |   |   |   |
|                                                                                                                                                                                                                                                                             |   |            |                  |   |         |   |   |   |
|      Series B Preferred Stock, Convertible,         20,625,000 Shares Authorized, 19,402,675 Issued and Outstanding     Common Stock, No Par Value, 300,000,000 Shares Authorized |   |            |  1,490,015       |   |         |   |  1,490,015 |   |
|         228,850,747 Shares Issued and Outstanding September 30, 2010 and        194,462,847 Shares Issued and Outstanding December  31, 2009                                           |   |            |  25,118,584      |   |         |   |  18,807,239 |   |
|  Accumulated Deficit                                                                                                                                                                                                                                                        |   |            | (21,124,750           | )      |         |   | (16,009,417 | ) |
|            Total Stockholders’ Equity                                                                                                                                                                               |   |            |   5,483,849 |   |         |   |   4,287,837 |   |
|                                                                                                                                                                                                                                                                             |   |            |                  |   |         |   |   |   |
|           Total Liabilities and Stockholders' Equity                                                                                                                                                                           |   | $               | 7,719,457             |   |         |   | 5,631,724 |   |
|                                                                                                                                                                                                                                                                             |   |            |                  |   |         |   |   |   |

----

|                                                                                     |   | Three MonthsEndedSeptember 30,2010 |        |    | Three MonthsEndedSeptember 30, 2009 |   |        | Nine Months EndedSeptember 30,2010 |   |   | Nine Months Ended September 30,2009 |    |
|------------------------------------------------------------------------------------------|--------|------------------------------------|-------------|---------|------------------------------------------|--------|-------------|-----------------------------------------|--------|--------|-----------------------------------------------|---------|
| Revenues:                                                                                |   |                               |        |    |                                     |   |        |                                    |   |   |                                          |    |   |   |   |   |
|      Licensing & Development                                     |   | $                                  | 159,984     |    |                                     | $      | 16,215      |                                    |   | $      | 367,668                                       |    |   | $ | 49,121 |   |
|                                                                                     |   |                               |        |    |                                     |   |        |                                    |   |   |                                          |    |   |   |   |   |
| Operating Expenses:                                                                      |   |                               |        |    |                                     |   |        |                                    |   |   |                                          |    |   |   |   |   |
|      Amortization                                               |   |                               | 65,680      |    |                                     |   | 65,680      |                                    |   |   | 197,040                                       |    |   |   | 197,040 |   |
|      Professional and Consulting Fees                           |   |                               | 149,266     |    |                                     |   | 130,675     |                                    |   |   | 478,793                                       |    |   |   | 379,338  |   |
|      Legal Fees                                                 |   |                               | 174,827     |    |                                     |   | 37,205      |                                    |   |   | 602,474                                       |    |   |   | 222,367 |   |
|      Research & Development Fees                            |   |                               | 132,444     |    |                                     |   | 6,526       |                                    |   |   | 325,403                                       |    |   |   | 18,494 |   |
|      Compensation                                               |   |                               | 202,500     |    |                                     |   | 230,117     |                                    |   |   | 931,425                                       |    |   |   | 668,421 |   |
|      Other General and Administrative Expenses                  |   |                               | 268,389     |    |                                     |   | 160,037     |                                    |   |   | 686,584                                       |    |   |   | 287,881 |   |
|           Total Operating Expenses     |   |                               | 993,106     |    |                                     |   | 630,239     |                                    |   |   | 3,221,719                                     |    |   |   | 1,773,541 |   |
|                                                                                     |   |                               |        |    |                                     |   |        |                                    |   |   |                                          |    |   |   |   |   |
|     Loss From Operations                                             |   |                               | (833,122    | )       |                                     |   | (614,024    | )                                       |   |   | (2,854,051                                    | )       |   |   | (1,724,420 | ) |
|                                                                                     |   |                               |        |    |                                     |   |        |                                    |   |   |                                          |    |   |   |   |   |
| Other Income (Expense)                                                                   |   |                               |        |    |                                     |   |        |                                    |   |   |                                          |    |   |   |   |   |
|      Interest Income                                            |   |                               | 3,139       |    |                                     |   | 1,454       |                                    |   |   | 13,303                                        |    |   |   | 3,868 |   |
|  Settlement Charges (Note G)                                                        |   |                               | (396,779    | )       |                                     |   | -           |                                    |   |   | (2,274,426                                    | )  |   |   | - |   |
|           Interest Expense             |   |                               |  -     |    |                                     |   | (10,320     | )                                       |   |   | (159                                          | )       |   |   | (10,683 | ) |
|           Total Other Income (Expense) |   |                               | (393,640    | )  |                                     |   | (8,866      | )                                  |   |   | (2,261,282                                    | )  |   |   | (6,815 | ) |
|                                                                                     |   |                               |        |    |                                     |   |        |                                    |   |   |                                          |    |   |   |   |   |
| Net Loss                                                                                 |   | $                                  | (1,226,762  | )       |                                     | $      | (622,890    | )                                       |   | $      | (5,115,333                                    | )       |   | $ | (1,731,235 | ) |
|                                                                                     |   |                               |        |    |                                     |   |        |                                    |   |   |                                          |    |   |   |   |   |
| Preferred stock dividends                                                                |   |                               | 56,763      |    |                                     |   | -           |                                    |   |   | 278,802                                       |    |   |   | - |   |
|                                                                                     |   |                               |        |    |                                     |   |        |                                    |   |   |                                          |    |   |   |   |   |
| Loss attributable to common shareholders                                                 |   | $                                  | (1,283,525  | )       |                                     | $      | (622,890    | )                                       |   | $      | (5,394,135                                    | )       |   | $ | (1,731,235 | ) |
|                                                                                     |   |                               |        |    |                                     |   |        |                                    |   |   |                                          |    |   |   |   |   |
|                                                                                     |   |                               |        |    |                                     |   |        |                                    |   |   |                                          |    |   |   |   |   |
| Weighted Average Outstanding Shares                                                      |   |                               | 221,349,240 |    |                                     |   | 169,522,590 |                                    |   |   | 211,103,478                                   |    |   |   | 169,522,590 |   |
|                                                                                     |   |                               |        |    |                                     |   |        |                                    |   |   |                                          |    |   |   |   |   |
|                                                                                     |   |                               |        |    |                                     |   |        |                                    |   |   |                                          |    |   |   |   |   |
| Loss Per Share (basic and diluted)                                                       |   | $                                  | (.01        | )       |                                     | $      | (.00        | )                                       |   | $      | (.03                                          | )       |   | $ | (.01 | ) |

| See accompanying notes to financial statements |   |   |   |   |   |   |   |   |   |   |   |
|------------------------------------------------|--------|--------|--------|--------|--------|--------|--------|--------|--------|--------|--------|

----

|                                                                                 |   | Nine Months EndedSeptember 30, 2010 |       |   | Nine Months EndedSeptember 30, 2009 |   |
|-------------------------------------------------------------------------------------------|--------|----------------------------------------------------|------------|--------|----------------------------------------------------|--------|
| Cash Flows From Operating Activities                                                      |   |                                               |       |   |                                               |   |   |   |
| Net Loss                                                                                  |   | $                                                  | (5,115,333 | )      |                                               | $      | (1,731,235 | ) |
| Adjustments to Reconcile Net Loss to Net Cash                                             |   |                                               |       |   |                                               |   |   |   |
|        Used by Operating Activities:                        |   |                                               |       |   |                                               |   |   |   |
| Stock-based Compensation                                                                  |   |                                               | 25,807     |   |                                               |   | 197,331 |   |
| Services Exchanged for Warrants                                                           |   |                                               | 99,366     |   |                                               |   | 128,701 |   |
|          Warrants Issued to Shareholders (Note F) |   |                                               | 597,647    |   |                                               |   | - |   |
| Increase in Deferred Charges                                                              |   |                                               | (43,149    | )      |                                               |   | (25,328 | ) |
| Depreciation and Amortization                                                             |   |                                               | 203,134    |   |                                               |   | 201,839 |   |

| Increase in Accounts Receivable                                                                                               |   |   | (330,961      | )      |   |   | -         |   |
|-------------------------------------------------------------------------------------------------------------------------------|--------|--------|---------------|--------|--------|--------|-----------|--------|
|          Increase in Allowance for Doubtful Accounts                                  |   |   | -             |   |   |   | 112,500   |   |
| Increase in Recoverable Development Costs                                                                                     |   |   | (28,195       | )      |   |   | -         |   |
| (Increase) Decrease in Interest Receivable                                                                                    |   |   | 288           |   |   |   | (156      | )      |
| Increase (Decrease) in Deferred Revenue                                                                                       |   |   | 430,472       |   |   |   | (11,621   | )      |
| (Increase) Decrease in Prepaid Expenses and Other Assets                                                                      |   |   | (79,416       | )      |   |   | 11,135    |   |
| Increase (Decrease) in Accounts Payable – Trade                                                                         |   |   | (59,135       | )      |   |   | 311,841   |   |
| Increase in Accrued Liabilities (Note G)                                                                                      |   |   | 355,740       |   |   |   | 51,121    |   |
|               Net Cash Used by Operating Activities     |   |   | (3,943,735    | )      |   |   | (753,872  | )      |
|                                                                                                                          |   |   |          |   |   |   |      |   |
| Cash Flows From Investing Activities:                                                                                         |   |   |          |   |   |   |      |   |
| Redemption of Certificates of Deposit                                                                                         |   |   | 471,564       |   |   |   | -         |   |
| Purchase of Equipment                                                                                                         |   |   | (5,164        | )      |   |   | (2,465    | )      |
|               Net Cash Provided by Investing Activities |   |   |  466,400 |   |   |   | (2,465    | )      |
|                                                                                                                          |   |   |          |   |   |   |      |   |
| Cash Flows From Financing Activities:                                                                                         |   |   |          |   |   |   |      |   |
| Proceeds from Sales of  Preferred B Stock                                                                           |   |   | -             |   |   |   | 600,000   |   |
| Proceeds from the Exercise of Warrants                                                                                        |   |   | 5,852,333     |   |   |   | -         |   |
| Proceeds from Borrowing                                                                                                       |   |   | -             |   |   |   | 500,000   |   |
| Dividends Paid                                                                                                                |   |   | (99,164       | )      |   |   | -         |   |
|                                                                                                                          |   |   |          |   |   |   |      |   |
|               Net Cash Provided by Financing Activities |   |   | 5,753,169     |   |   |   | 1,100,000 |   |
|                                                                                                                          |   |   |          |   |   |   |      |   |
|                                                                                                                          |   |   |          |   |   |   |      |   |
| Net Increase in Cash                                                                                                          |   |   | 2,275,834     |   |   |   | 343,663   |   |
|                                                                                                                          |   |   |          |   |   |   |      |   |
| Cash, at Beginning of Period                                                                                                  |   |   | 2,328,912     |   |   |   | 325,887   |   |
|                                                                                                                          |   |   |          |   |   |   |      |   |
| Cash, at End of Period                                                                                                        |   | $      | 4,604,746     |   |   | $      | 669,550   |   |
|                                                                                                                          |   |   |          |   |   |   |      |   |
| Supplemental disclosures of cash flow information:                                                                            |   |   |          |   |   |   |      |   |
| Cash Paid for Interest                                                                                                        |   | $      | 159           |   |   | $      | 601       |   |
|                                                                                                                          |   |   |          |   |   |   |      |   |
|                                                                                                                          |   |   |          |   |   |   |      |   |
| See accompanying notes to financial statements.                                                                               |   |   |          |   |   |   |      |   |

----

----

----

|                            |   |                          |              |    |                          |
|---------------------------------|--------|-------------------------------|-------------------|---------|-------------------------------|
|   2009                |   | Option and WarrantShares |              |    | WeightedAverageExercise Price |
| Outstanding, January 1, 2009    |   |                          | 128,777,644       |    |                          |   | $0.16 |   |
| Granted                         |   |                          | 5,000,000         |    |                          |   | $0.08 |   |
| Exercised                       |   |                          | (17,503,073       | )       |                          |   | $0.14 |   |
| Expired un-exercised            |   |                          |  (15,659,394 | )  |                          |    | $0.15 |   |
| Outstanding, December 31, 2009  |   |                          | 100,615,177       |    |                          |   | $0.16 |   |
|                            |   |                          |              |    |                          |   |   |   |
| 2010                            |   |                          |              |    |                          |   |   |   |
| Granted*                        |   |                          | 19,375,000        |    |                          |   | $0.22 |   |
| Exchanged*                      |   |                          | (32,527,776       | )       |                          |   | $0.17 |   |
| Exercised                       |   |                          | (34,387,903       | )       |                          |   | $0.14 |   |
| Expired un-exercised            |   |                          | (18,949,498       | )       |                          |   | $0.19 |   |
| Outstanding, September 30, 2010 |   |                          | 34,125,000        |    |                          |   | $0.15 |   |

----

| Exercise Prices                |   |   | NumberOutstanding |       |            | Weighted-Average Remaining Contractual Life (years) |   |   | NumberExercisable |   |   | Weighted Average Remaining Contractual Life (years) of Exercisable Warrants andOptions |             |
|--------------------------------|--------|--------|-------------------|------------|-----------------|----------------------------------------------------------|--------|--------|-------------------|--------|--------|----------------------------------------------------------------------------------------|------------------|
|                           |   |   |              |       |            |                                                     |   |   |              |   |   |                                                                                   |             |
|                           | $0.08  |   |              |       | 12,250,000      |                                                     |   |   | 3.0               |   |   |                                                                                   |  12,250,000 |   |   |   | 5.0 |   |
|                           | $0.13  |   |              |       | 2,500,000       |                                                     |   |   | 2.0               |   |   |                                                                                   | 2,500,000        |   |   |   | 2.0 |   |
|                           | $0.15  |   |              |       | 1,000,000       |                                                     |   |   | 5.0               |   |   |                                                                                   | -                |   |   |   | 5.0 |   |
|                           | $0.17  |   |              |       | 6,875,000       |                                                     |   |   | 2.0               |   |   |                                                                                   | 6,875,000        |   |   |   | 2.0 |   |
|                           | $0.25  |   |              |       | *10,000,000     |                                                     |   |   | 1.5               |   |   |                                                                                   | *10,000,000      |   |   |   | 1.5 |   |
|                           | $0.26  |   |              |       |  1,500,000 |                                                     |   |   | 4.0               |   |   |                                                                                   |  250,000    |   |   |   | 4.5 |   |
|      Total |   |   |              | 34,125,000 |            |                                                     |   |   |              |   |   |  33,125,00                                                                        |             |   |   |   |   |

----

----

----

----

----

----

----

|                 |   | Total  |    |   | 1 YearOr Less |   |    | More Than 1 Year |   |
|----------------------|--------|--------|---------|--------|---------------|--------|---------|----------------------------|--------|
| Accrued Compensation |   | $      | 62,500  |   |          | $      | 62,500  |                       |   | $ | - |   |
| Office Lease         |   |   | 204,160 |   |          |   | 40,140  |                       |   | $ | 164,020 |   |
| Total                |   | $      | 360,781 |   |          | $      | 196,761 |                       |   | $ | 164,020 |   |

----

----

----

| 31.1 | Rule 13a-14(a)/15(d)-14(a) Certifications of Chief Executive Officer. |
|------|-----------------------------------------------------------------------|

| 31.2 | Rule 13a-14(a)/15(d)-14(a) Certifications of Principal Financial Officer. |
|------|---------------------------------------------------------------------------|

| 32.1 | Section 1350 Certification of Chief Executive Officer and Principal Financial Officer. |
|------|----------------------------------------------------------------------------------------|

| 10.1 | Settlement Agreement with 2007 Private Placement Lead Investor |
|------|----------------------------------------------------------------|

| 10.2 | Settlement Agreement with William F. Quirk, Jr. |
|------|-------------------------------------------------|

----

|   |                    | Health Discovery Corporation                                                                                                                                                                                                                                                        |   |
|--------|-------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|
|   |                    | Registrant                                                                                                                                                                                                                                                                          |   |
|   |                    |                                                                                                                                                                                                                                                                                |   |
|   | Date: November 15, 2010 | /s/ Stephen D. Barnhill                                           |   |
|   |                    | Printed Name: Stephen D. Barnhill M.D.                                                                                                                                                                                                                                              |   |
|   |                    | Title: Chief Executive Officer                                                                                                                                                                                                                                                      |   |
|   |                    |                                                                                                                                                                                                                                                                                |   |
|   |                    |                                                                                                                                                                                                                                                                                |   |
|   | Date: November 15, 2010 | /s/ Thomas L. Gallagher                                                          |   |
|   |                    | Printed Name: Thomas L. Gallagher                                                                                                                                                                                                                                                   |   |
|   |                    | Title: President, Chief Operating Officer and                                                                                                                                                                                                                                       |   |
|   |                    | Principal Financial Officer                                                                                                                                                                                                                                                         |   |